+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Gastrointestinal stromal tumors A model for understanding solid tumor biology and development of targeted therapies, or just another low-hanging fruit?

Gastrointestinal stromal tumors A model for understanding solid tumor biology and development of targeted therapies, or just another low-hanging fruit?

Asia-Pacific Journal of Clinical Oncology 4(4): 185-187

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 063675999

Download citation: RISBibTeXText

DOI: 10.1111/j.1743-7563.2008.00220.x

Related references

Liquid biopsies for solid tumors: Understanding tumor heterogeneity and real time monitoring of early resistance to targeted therapies. Pharmacology and Therapeutics 157: 120-124, 2016

Targeted therapies in gastrointestinal stromal tumors. Seminars in Diagnostic Pathology 25(4): 295-303, 2008

Gastrointestinal stromal tumors: molecular mechanisms and targeted therapies. Pathology Research International 2011: 708596, 2011

Predictors of response to targeted therapies for gastrointestinal stromal tumors. Archives of Pathology and Laboratory Medicine 136(5): 483-489, 2012

Gastrointestinal stromal tumors (GIST): at the forefront of targeted therapies. Medecine Sciences 29(6-7): 630-636, 2013

Targeted therapies of gastrointestinal stromal tumors (GIST)--the next frontiers. Biochemical Pharmacology 80(5): 575-583, 2010

Gastrointestinal stromal tumors (GIST)--a paradigm of successful targeted therapy of solid tumors. Acta Medica Croatica 60(5): 471-475, 2007

Biology and targeted therapy of gastrointestinal stromal tumors. Tumor Research 40: 1-11, 2005

Monitoring the effect of targeted therapies in a gastrointestinal stromal tumor xenograft using a clinical PET/CT. Molecular Imaging and Biology 13(6): 1234-1240, 2012

Implications of mutational analysis for the management of patients with gastrointestinal stromal tumors and the application of targeted therapies. Cancer Investigation 28(8): 839-848, 2010

Novel receptor tyrosine kinase targeted combination therapies for imatinib-resistant gastrointestinal stromal tumors (GIST). Oncotarget 6(4): 1954-1966, 2015

Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers. American Journal of Cancer Research 1(6): 787-805, 2011

Gastrointestinal stromal tumors: recent advances in understanding of their biology. Human Pathology 30(10): 1213-1220, 1999

Dual Energy Ct for Monitoring Targeted Therapies in Patients with Advanced Gastrointestinal Stromal Tumor: Initial Results. Current Pharmaceutical Biotechnology 12(4): 547-557, 2011

Dual energy CT for monitoring targeted therapies in patients with advanced gastrointestinal stromal tumor: initial results. Current Pharmaceutical Biotechnology 12(4): 547-557, 2011